Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Articles|April 14, 2020
Telepsychiatry Comes of Age, Reluctantly
Author(s)Chris Aiken, MD
Practical tips to help clinicians get started or to hone skills in telepsychiatry.
Advertisement
Chris Aiken, MD, provides practical tips to help clinicians get started or to hone their skills in telepsychiatry.
Advertisement
Related to this article
There is a question older than medicine, and perhaps older than philosophy, that psychiatry has largely avoided: What makes us human?
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
4
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
5